APSR2026-387

 
Late-Breaking
Submitted
Poster Presentation
YIA01-001
AP02-013
P21
https://storage.unitedwebnetwork.com/files/1285/1220090-46903-APSR2026_oral_261118_440108.pptx
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220090-46904-APSR2026_ポスター(A0)_261118_440109.pdf
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
7

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Keiji Fujiwara * Fukujuji Hospital, Japan Anti-Tuberculosis Association Respiratory Disease Center Tokyo Japan The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association Department of Mycobacterium Reference and Research Tokyo Japan
Fumiya Watanabe - Meiji Pharmaceutical University Department of Pharmacometrics and Pharmacokinetics Tokyo Japan
Koji Furuuchi - Fukujuji Hospital, Japan Anti-Tuberculosis Association Respiratory Disease Center Tokyo Japan
Masashi Ito - Fukujuji Hospital, Japan Anti-Tuberculosis Association Respiratory Disease Center Tokyo Japan
Tatsuya Kodama - Fukujuji Hospital, Japan Anti-Tuberculosis Association Respiratory Disease Center Tokyo Japan
Takashi Yoshiyama - Fukujuji Hospital, Japan Anti-Tuberculosis Association Respiratory Disease Center Tokyo Japan
Kozo Morimoto - Fukujuji Hospital, Japan Anti-Tuberculosis Association Respiratory Disease Center Tokyo Japan
 
 
 
 
 
 
 
 
Presenting Author Details
Keiji
Fujiwara
fujikeiji@gmail.com
+818031773047
31-40
Japan
Original Research
Radiologic identification of asymptomatic Mycobacterium avium complex pulmonary infections
Maximum 25 words
Abstract Content
Although international nontuberculous mycobacterial pulmonary disease (NTM-PD) guidelines highlight symptom presence at diagnosis, the clinical characteristics of asymptomatic Mycobacterium avium complex pulmonary infection (MAC-PI) patients remain understudied. We clarified the clinical characteristics and course of asymptomatic MAC-PI patients.
We retrospectively analyzed 200 consecutive patients with MAC-PIs and adequate available data who newly met the microbiological and radiological criteria for NTM-PD at Fukujuji Hospital from January 2018 to June 2020. We compared the clinical characteristics and course of asymptomatic patients with symptomatic patients and evaluated factors influencing treatment initiation through multivariate analysis.
111 patients were symptomatic and 89 were asymptomatic at diagnosis. While the proportion was significantly lower than that in the symptomatic group (28.8%), 15.7% of asymptomatic group patients had cavitary lesions (P = 0.042). In the asymptomatic group, treatments were initiated in 38 (42.7%) patients, and cavitary lesions, a positive acid-fast bacilli smear, and younger age were independent risk factors for treatment initiation. Among 22 (57.9%) patients who experienced disease progression necessitating treatment during follow-up, 13 (34.2%) displayed radiological progression without any worsening of symptoms. Agents used for treatment were consistent across the groups, with no significant differences in culture conversion, microbiological recurrence rates, or spontaneous culture conversion rates.
Routine health checkups and radiological examinations can detect clinically important MAC-PIs even in the absence of symptoms. Considering that the clinical course of asymptomatic MAC-PI patients is largely similar to that of symptomatic patients, timely and appropriate management and intervention are essential for all MAC-PI patients.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Mycobacterium avium, symptom, health checkup
maximum 3 keywords and no abbreviations, separated by commas
 
251